Antitumor Activity (In-vitro) of Extracellular Polysaccharide Produced by Ropy Lactobacillus delbrueckii ssp. bulgaricus Isolated from Tradisional Fermented Milk by Malaka, Ratmawati
Ratmawati Malaka et al, IJCPS, 2016, 4(5): 246–249 CODEN (USA): IJCPNH | ISSN: 2321-3132
International Journal of Chemistry and Pharmaceutical Sciences 246
International Journal of Chemistry and
Pharmaceutical SciencesJournal Home Page: www.pharmaresearchlibrary.com/ijcps
Research Article Open Access
Antitumor Activity (In-vitro) of Extracellular Polysaccharide Produced by Ropy
Lactobacillus delbrueckii ssp. bulgaricus Isolated from Tradisional Fermented Milk
Ratmawati Malaka*, Efendi Abustam and Sudirman Baco
Hasanuddin University, Faculty of Animal Science, Jl. Perintis Kemerdekaan Km 10 Tamalanrea, Makassar, Indonesia.
A B S T R A C T
An extracellular polysaccharide (EPS) was purified by ethanol precipitation from culture supernatant of Ropy strains of
Lactobacillus delbrueckii ssp. bulgaricus, a lactic acid bacteria that was isolated from commercial yoghurt.  The EPS was
produced under aerobic conditions in a medium Skim Milk Reconstitution (SMR) 10% (w/v). This EPS have studied to
potential health – promoting effect as antitumor activity.  The objective of this study was to determine of potential of the EPS
on proliferation of tumor cell in vitro. EPS with different concentration (0.01; 0.02; 0.05; and 0.001 mg/ml) was examined in
vitro for antitumor activity on Leukemia K-562 and Hela cell.  Result of these studies had showed that EPS in doses 50 g/ml
can inhibited of 45.4 % of tumor leukemia and 59.2% for tumor human cervix (Hela cell).
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1. Introduction
Microbial exopolysaccharides often show clearly identified
properties that form the basis for wide range of applications
in food as industrial thickeners, gels and stabilizers
(Malaka, 1997; Malaka 2005), pharmaceutical, petroleum,
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and other industries.  Polysaccharides with have potential as
antitumor against certain allogenic tumors have been
isolated from diverse sources including higher plants, fungi,
lichen, bacteria and yeast.  The nature of their antitumor
action is not entirely clear, but the polysaccharides from
botanical sources cannot be shown to exert any direct action
on tumor cell.  Their antitumor action must therefore be
considered to be dependent on the reaction of the host or
cell (Sasaki et al., 1987).
Kitazawa et al. (1990) have been shown that Lactococcus
lactis subsp. cremoris isolated from Scandinavian ropy sour
milk “viili” would protect the growth of S-180 tumor in
ICR mice. A later study (Kitazawa, Yamauchi and Itoh,
1992) showed a significant increase of the B-cell dependent
mitogenic activity induced by the slime material products
from L. lactic subsp. cremoris KVS 20. The yoghurt starter
Lb. delbrueckii subsp. bulgaricus OLL 1073R-1, which
produces an EPS, has been reported to exert a host-
mediated antitumor activity (Maduri and Prabhakar, 2014).
By in the long time ago in the Eastmidle Asia was
recommended that fermented milk have beneficial health
effect and recovery from many diseases (Tamime and
Robinson, 1985).  Futhermore, this effect was known that
because of microorganism are contains by lactic acid
bacteria in fermented milk.  So that the lactic acid bacteria
produced polysaccharide excreted extra cell (finally known
as exopolysaccharide EPS) where have beneficial function
as medicine or food addictive (Cerning, 1990; Malaka,
1997 and Malaka, 2005).  There is much hypothesis that
need confirmed about the tumor activity of LAB such as
Lactobacillus bulgaricus include it production EPS are (1)
direct inhibition to procarsinogens by binding, blockading,
or remove the carsinogen: (2) reduce bacteria produce
enzyme that convert procarsinogens to carsinogens; (3)
decrease intestinal pH cause of reduce the microbial activity
and bile salt; reduce the transit time of pathogen bacteria
thorough intestinal so reduce the toxin as procarsinogen; (4)
activated the host immune system (Salminen and Wright,
1993; Fooks et al., 1999).
The name exopolysahharides (EPS) as proposed by
Sutherland in 1972 provides a general term for all these
form of bacterial polysaccharides found outside the cell
wall.  Based on the composition of EPS, the polymer
separated into two major groups that homopolysaccharides
(for example dextran and mutan) and heteropolysahharides
(EPS of L. bulgaricus).  There have been reported that
bacterial bacterial EPS was generally used as food addictive
to increase the food quality, antihipertention, antivirus,
cosmetic, or anti AID’S.  One of the bacterial EPS that have
produced by commercial scale are “Curdlan” is EPS from
Alcaligenes faecalis var myxogenes (Malaka, 1997).
According the Yamanaka (1992) showed that EPS LAB
have antitumor effect on tumor growth in mice.  Mice by
intravenous implantation with Melanoma B-16 tumor cell
high metastation 5.1 x 105 cells and treatment with EPS
show the inhibited the metastases of tumor cell to
pulmonary system 29.4%.  Treatments by EPS per oral
have the effect for increase the antibody immune system.
Studied about antitumor activity by milk fermented culture
starter such as L. bulgaricus not focus to its EPS production
but still focus to LAB self (Cerning, 1990).  However,
researchers suggested that the role important to antitumor
activity are polysaccharide as metabolite product by LAB
(Sasaki et al., 1978; Kelkar et al., 1988; Kitazawa et al.,
1993; Shiraguchi et al., 1994).  The researches not yet
isolated EPS before examined to animal laboratory.  The
objective of this study was to determine of EPS extracted
from L. bulgaricus in reconstituted skim milk medium on
the ability to inhibited proliferation of Leukemia and Hela
cell line in vitro.
2. Experimental
Propagation and medium of Lactobacillus bulgaricus
Lactobacillus bulgaricus was isolated from commercial
ropy yoghurt and routinely propagated in Reconstituted
Skim Milk (RSM) 2 times a week.  The research was
conducted in Biotechnology Laboratory of Research
Center, Hasanuddin University, Indonesia.
Production and Isolation of Exopolysaccharide (EPS)
Exopolysaccharide produced by L. bulgaricus was doing in
10 liter bioreactor used medium according to the modified
of Malaka (2004).  The medium was used Reconstituted
Skim Milk (RSM) 10% + glucose 1% + sodium citric 0.5%
where incubated at 30oC for 16 hr with initial pH 6.5.
Exopolysaccharide was isolated by Shellhaass Methods
(1983) modified that flocculants from cell-free medium was
added the isopropyl alcohol and storage in 4oC before
centrifugation (4000 x g for 10 min).  The crude EPS was
freeze dried and storage in -18oC before use in experiment.
Tumor cells
Leukemia K-562 and Hela cell tumor were obtain from
Laboratory of Tissue Culture, Division of  Clinical
Pathology, Department of Reproduction and Pathological,
Faculty of Veterinary Medicine, Bogor Agriculture
University.  The tumor cell have been maintained with
sterile condition for prevent virus and bacterial
contamination by penicillin-streptomycin with doses 100
IU-100 g/ml administration.
Antiproliferation test in vitro methods
The leukemia K-562 and Hela tumor cells ( 1 x 105 cells)
were incubated in a CO2 incubator at 37oC in a medium
containing EPS suspension in various concentration (0; 1;
5; 10; 50 μg/ml).  The each treatment repeats for tree times.
One milliliter of suspension of line cell K-562 and Hela cell
(105cells/ml) in 24 tissue culture well plate added with EPS.
Each plate was incubated at 37oC, 5% CO2.  The medium
was added 20% of calf serum. The cell was harvested if the
control cell in optimal growth condition (if the cell was
covered 70% of inside of well plate, about 3 – 4 days).  The
medium was resuspensed with 500 μl of 2 mM EDTA-PBS
solution.  The cell removed from the well plate by trypsin
0.05%. The total cells were measurement by
Haemocytometer Neubauer. The cell was stained with
0.17% of trypan blue and view by light microscopic (100 x
magnification) (Yamamoto, 1994; Priosoeryanto et al.,
1995a, b; 2001; 2002 a, b, c). The growth activity (%) was
calculated by the following equation:
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% growth activity =
controlcelltumorthenumbertotalofmean
treatmentcelltumorthenumbertotalofmean
x
100%
3. Result and Discussion
Table 1. shows the effect of EPS of L. delbrueckii ssp.
bulgaricus by different doses on the proliferation of human
leukemia cell (LeukemiaK-562). Antitumor activity process
on Leukemia K-562 tumor cell at a dose 50 μg/ml) showed
significantly inhibited growth cell  by 45.4%.  It was
noteworthy that even 50 μg/ml treatment caused a well
defined proliperative inhibition effect.
The result suggested that the leukemia cell decrease the cell
number and the size of cell by direct contact of EPS.  The
phenomena may cause of sytolitic activity of EPS.
Generally EPS can give a sytolitic effect in recovery of
infection disease and tumor (Zheng et al. (2006).
Exopolysaccharide as macromolecule with high of weigh
molecule mass are a primary effect on inhibition of cell
tumor growth. This effect may cause of direct sytosidal
action effect on cell, like generally biological mechanism.
Macromolecules disturb the cell metabolism by division
cell inhibition.  The experiment suggested that the tumor
cell growth inhibiting activity because of potential
inhibition proliferation effect and cell colony formed.
Antitumor activity process on Hela tumor cell  at a dose 50
μg/ml) showed significantly inhibited growth cell  by 59.2
%. The effect of EPS on Hela cell most effective than on
Leukemia cell on inhibition of growth of cell.
Several EPS have been shown to posses’ immunological
activities with potential pharmacological applications as
biological response modifier (BMRs).  BMRs are agents
that alter the normal immune response and whose
mechanisms of action include induction of cytokines.
Research on pharmacological applications of BMRs has led
to development of both immunosuppressive and
immunostimulating drugs that are effective in preventing
the rejection of transplanted organs, for the treatment of
some autoimmune diseases, as cancer immunotherapy.  A
number a bacterial EPS have been identified as BMRs and
have been found to have the ability to stimulate tumor
rejection (Ruiz-Bravo et al., 2001).
Although polysaccharides are considered to be T-cell-
independent antigens, a number of microbial EPS are
immunomodulators, with activities for T cells and
macrophages. The possibility of inhibition mechanism on
tumor cell was suggested. Polysaccharide A, a component
of the capsular complex of Bacteroides fragilis, possesses
mitogenic activity fot T lymphocytes and the production of
interleukin-2 (IL-2) by CD4+ T cells appears to play an
essential role in the in vivo (Tzianabos, 2000).  A number
of fungi and yeast produce β-(1-3)-glucans with
imunomodulatory properties.  Studies on the mechanisms of
immunomodulatory by a soluble derivate of β-(1,3)-glucan
have shown that it has the ability to prime granulocytes and
macrophages for enhanced cytokine release, reactive
nitrogen intermediate production, and bactericidal capacity
in response to a secondary stimulus.
Table 1: Effect of EPS of L. delbrueckii ssp. bulgaricus on Leukemia K-562 (Erythroleukemia cell line)
Treatment of EPS (doses in μg/ml) Mean of cell (x 104) % growth % Inhibition
Control (0.0) 69.2 100 0
1 59.2 85.5 14.5
5 56.6 81.8 18.2
10 44.4 64.2 35.8
50 37.8 54.6 45.4
Table 2: Effect of EPS of L. delbrueckii ssp. bulgaricus on Hela cell (Human Cervix Tumor)
Treatment of EPS (doses in μg/ml) Mean of cell (x 104) % growth % Inhibition
Control (0.0) 75.0 100 0
1 64.6 86.1 13.9
5 61.8 82.4 17.6
10 48.6 64.8 35.2
50 30.6 40.8 59.2
4. Conclusion
Exopolysaccharides of Lactobacillus delbrueckii subsp.
Bulgaricus shows of potensial application as antitumor.
Result of these studies had showed that EPS in doses 50
g/ml can inhibited of 45.4 % of tumor leukemia and
59.2% for tumor human cervix (Hela cell).
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